These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 30018005)
21. The impact of chromatin organization of vitamin D target genes. Carlberg C; Dunlop TW Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674 [TBL] [Abstract][Full Text] [Related]
22. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M; Freedman LP; Li H; Christakos S Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [TBL] [Abstract][Full Text] [Related]
23. Genome-wide effects of chromatin on vitamin D signaling. Hanel A; Malmberg HR; Carlberg C J Mol Endocrinol; 2020 May; 64(4):R45-R56. PubMed ID: 32229699 [TBL] [Abstract][Full Text] [Related]
24. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter. Sinkkonen L; Malinen M; Saavalainen K; Väisänen S; Carlberg C Nucleic Acids Res; 2005; 33(8):2440-51. PubMed ID: 15863722 [TBL] [Abstract][Full Text] [Related]
25. Differential gene regulation by a synthetic vitamin D receptor ligand and active vitamin D in human cells. Iwaki M; Kanemoto Y; Sawada T; Nojiri K; Kurokawa T; Tsutsumi R; Nagasawa K; Kato S PLoS One; 2023; 18(12):e0295288. PubMed ID: 38091304 [TBL] [Abstract][Full Text] [Related]
26. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
27. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol. Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583 [TBL] [Abstract][Full Text] [Related]
28. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1). Song CS; Echchgadda I; Seo YK; Oh T; Kim S; Kim SA; Cho S; Shi L; Chatterjee B Mol Endocrinol; 2006 Apr; 20(4):795-808. PubMed ID: 16357103 [TBL] [Abstract][Full Text] [Related]
29. Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening. Seuter S; Neme A; Carlberg C PLoS One; 2014; 9(4):e96184. PubMed ID: 24763502 [TBL] [Abstract][Full Text] [Related]
30. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Saramäki A; Banwell CM; Campbell MJ; Carlberg C Nucleic Acids Res; 2006; 34(2):543-54. PubMed ID: 16434701 [TBL] [Abstract][Full Text] [Related]
31. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells. Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427 [TBL] [Abstract][Full Text] [Related]
32. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice. Chow EC; Quach HP; Vieth R; Pang KS Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451 [TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428 [TBL] [Abstract][Full Text] [Related]
34. Switches in histone modifications epigenetically control vitamin D3-dependent transcriptional upregulation of the CYP24A1 gene in osteoblastic cells. Moena D; Merino P; Lian JB; Stein GS; Stein JL; Montecino M J Cell Physiol; 2020 Jun; 235(6):5328-5339. PubMed ID: 31868234 [TBL] [Abstract][Full Text] [Related]
35. Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation. Meyer MB; Benkusky NA; Lee CH; Pike JW J Biol Chem; 2014 Jul; 289(28):19539-54. PubMed ID: 24891508 [TBL] [Abstract][Full Text] [Related]
36. The transcriptional regulator BCL6 participates in the secondary gene regulatory response to vitamin D. Nurminen V; Neme A; Ryynänen J; Heikkinen S; Seuter S; Carlberg C Biochim Biophys Acta; 2015 Mar; 1849(3):300-8. PubMed ID: 25482012 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms of Enhancer-mediated Hormonal Control of Vitamin D Receptor Gene Expression in Target Cells. Lee SM; Meyer MB; Benkusky NA; O'Brien CA; Pike JW J Biol Chem; 2015 Dec; 290(51):30573-86. PubMed ID: 26504088 [TBL] [Abstract][Full Text] [Related]
38. Genomic Determinants of Vitamin D-Regulated Gene Expression. Pike JW; Meyer MB; Benkusky NA; Lee SM; St John H; Carlson A; Onal M; Shamsuzzaman S Vitam Horm; 2016; 100():21-44. PubMed ID: 26827947 [TBL] [Abstract][Full Text] [Related]
39. Minireview: vitamin D receptor: new assignments for an already busy receptor. Norman AW Endocrinology; 2006 Dec; 147(12):5542-8. PubMed ID: 16946007 [TBL] [Abstract][Full Text] [Related]
40. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells. Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]